| In vivo gene editing in dystrophic mouse muscle and muscle stem cells M Tabebordbar, K Zhu, JKW Cheng, WL Chew, JJ Widrick, WX Yan, ... Science 351 (6271), 407-411, 2016 | 1267 | 2016 |
| A multifunctional AAV–CRISPR–Cas9 and its host response WL Chew, M Tabebordbar, JKW Cheng, P Mali, EY Wu, AHM Ng, K Zhu, ... Nature methods 13 (10), 868-874, 2016 | 705 | 2016 |
| In situ modification of tissue stem and progenitor cell genomes JM Goldstein, M Tabebordbar, K Zhu, LD Wang, KA Messemer, B Peacker, ... Cell reports 27 (4), 1254-1264. e7, 2019 | 53 | 2019 |
| dCas9-based gene editing for cleavage-free genomic knock-in of long sequences C Wang, Y Qu, JKW Cheng, NW Hughes, Q Zhang, M Wang, L Cong Nature cell biology 24 (2), 268-278, 2022 | 50 | 2022 |
| Microbial single-strand annealing proteins enable CRISPR gene-editing tools with improved knock-in efficiencies and reduced off-target effects C Wang, JKW Cheng, Q Zhang, NW Hughes, Q Xia, MM Winslow, L Cong Nucleic acids research 49 (6), e36-e36, 2021 | 34 | 2021 |
| Therapeutic Gene Editing in Muscles and Muscle Stem Cells M Tabebordbar, J Cheng, AJ Wagers Genome Editing in Neurosciences, 103, 2017 | 1 | 2017 |